This free survey is powered by
  1. Surveys
  2. 2015
  3. August
  4. P
  5. Pressurized Infusion - Phaco Survey

Pressurized Infusion - Phaco Survey

Pressurized Infusion – Phaco Survey
 
 
Thank you for taking the time to complete this survey. We would like your input to help determine the importance of new features for our current platform upgrades as well as new features for our Next Generation Phaco platforms. The survey is focused on Pressurized Infusion (PI) and Intra-ocular Pressure (IOP) management and we ask that you complete the survey based on input you have received from the customers in your sales territory.

Background
Pressurized Infusion has been on the market for years primarily for vitrectomy. Recently, Alcon has marketed PI as the solution to chamber instability. All of our major competitors offer pressurized infusion. Most surgeons agree that Alcon’s Centurion Active Fluidics is more stable than the Infiniti Intrepid Fluidics. At the ASCRS Phaco Advisory Board meeting, surgeon attendees recommended that AMO should consider offering PI as an accessory to Signature and Intuitiv and any new generation console. It is important to realize that PI offers advantages and concerns. Post Occlusion Surge (POS) is not solved only on the irrigation side of the chamber-balance equation. Variable PI can increase the supply of irrigation fluid particularly with small lumen tips and sleeves. It can help manage the interference of IV pole with low ceilings.

Please complete all questions keeping your customer’s point of view in mind.
 
 
1) Approximately what percent of your current customers and Alcon customers who use or have used WhiteStar Signature or Compact consider the chamber stability/fluidic performance to be inadequate?

Choose one per row
None of my customers Approximately 10% of customers Approximately 25% of customers Approximately 50% of customers Approximately 75% of customers Almost every customer
AMO WhiteStar Signature Customers
 
 
None of my customers Approximately 10% of customers Approximately 25% of customers Approximately 50% of customers Approximately 75% of customers Almost every customer
AMO Compact Customers
 
 
None of my customers Approximately 10% of customers Approximately 25% of customers Approximately 50% of customers Approximately 75% of customers Almost every customer
Alcon Customers who use/have used WhiteStar Signature
 
 
None of my customers Approximately 10% of customers Approximately 25% of customers Approximately 50% of customers Approximately 75% of customers Almost every customer
Alcon Customers who use/have used Compact
 
2) How often do you hear from customers regarding the following aspects of Pressurized Infusion?

Choose one per row

PI Feature
Never Occasionally Often
Chamber Stability
Latest Technology
BSS tracking and empty bottle warning
Eliminating the IV pole
Accuracy perception of setting an IOP number
Competitive bid sheet requirement
Easier set up due to BSS bag
 
 
 
3) What other comments do you hear from customers regarding Pressurized Infusion?
   
 
 
4) Please rate the relative importance of the following features related to Pressurized Infusion
using a Scale of 1 to 6 with 1 = Do not Need and 6 = Must Have

PI Feature
Don't NeedMust Have
1 2 3 4 5 6
BSS usage tracker
BSS empty bottle warning
BSS in a bag versus a bottle
BSS bag in the phaco pack
30 ml cornea wetter BSS bottle in the phaco pack
IOP management
 
 
 
5) If AMO offered Pressurized Infusion, it should be offered as:

Choose one
 
Standard Feature on the Next Generation Phaco
 
Upgraded feature available for Signature and Intuitiv
 
Optional Phaco Pack that adds Pressurized Infusion on current and new console platforms
 
None of the above; AMO should not offer Pressurized Infusion
 
 
 
6) If AMO offered Pressurized Infusion, in what segment does the need for Pressured Infusion most exist?

Choose one
 
Exclusively in the Premium segment
 
All segments
 
None of the above; AMO should not offer Pressurized Infusion
 
 
 
7) What percent of your customers are asking for Pressurized Infusion?

Choose one
 
None of my customers
 
Approximately 10% of customers
 
Approximately 25% of customers
 
Approximately 50% of customers
 
Approximately 75% of customers
 
Almost every customer
 
 
 
We would now like to ask some questions related to IOP Management / Pressure Measurement

There are many approaches to IOP management. Most recently, setting the IOP on the console has been marketed as standard of care. This indirect method of IOP management could be improved. A pressure transducer (PT) is a device that directly measures IOP. It can be used not only during phaco surgery but throughout the entire case to maintain constant IOP and reduce IOP fluctuations. Often a secondary source of BSS (chamber maintainer) can be added to this device to assure constant IOP.
 
 
 
8) How many of your customers use a chamber maintainer to manage IOP?

Choose one
 
None of my customers
 
Approximately 10% of customers
 
Approximately 25% of customers
 
Approximately 50% of customers
 
Approximately 75% of customers
 
Almost every customer
 
 
9) Please rate the relative importance of the following features related to Pressurized Infusion
using a Scale of 1 to 6 with 1 = Do not Need and 6 = Must Have

Chamber Maintenance Attributes
Don't NeedMust Have
1 2 3 4 5 6
Maintains IOP during lens implantation and intra-operative diagnostics
Displays “Set” and “Actual” IOP throughout the case
Tracks IOP variance measurements for case review
 
 
 
10) What are the current unmet customer needs for AMO’s Phaco platforms?
   
 
 
 
11) What additional features would you like to add to our Next Generation Phaco platform?
   
 
 
 
Full Name:
   
 
 
Title:
   
 
 
Country:
   
Company Confidential-Do not distribute
Copyright 2015 Abbott Laboratories. Abbott Park, IL, U.S.A.